Lido Advisors LLC Makes New $474,000 Investment in Acadia Healthcare Company, Inc. $ACHC

Lido Advisors LLC bought a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund bought 20,271 shares of the company’s stock, valued at approximately $474,000.

A number of other hedge funds have also modified their holdings of the business. Goldman Sachs Group Inc. raised its holdings in Acadia Healthcare by 417.8% in the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock valued at $67,099,000 after buying an additional 3,815,471 shares during the period. Jefferies Financial Group Inc. purchased a new stake in shares of Acadia Healthcare in the 4th quarter valued at approximately $47,960,000. Wellington Management Group LLP lifted its holdings in shares of Acadia Healthcare by 24.9% in the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after acquiring an additional 2,350,760 shares during the last quarter. Vaughan Nelson Investment Management L.P. purchased a new position in shares of Acadia Healthcare during the 1st quarter worth approximately $43,017,000. Finally, Invenomic Capital Management LP increased its holdings in Acadia Healthcare by 71.0% in the 4th quarter. Invenomic Capital Management LP now owns 3,312,043 shares of the company’s stock valued at $46,998,000 after purchasing an additional 1,375,647 shares during the last quarter.

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $28.14 on Friday. The firm has a 50 day moving average of $28.10 and a two-hundred day moving average of $23.70. The stock has a market capitalization of $2.62 billion, a PE ratio of -2.26, a P/E/G ratio of 9.09 and a beta of 0.64. The company has a quick ratio of 1.71, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $35.83.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.03. The business had revenue of $865.84 million for the quarter, compared to analyst estimates of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The company’s revenue was down .4% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. On average, research analysts predict that Acadia Healthcare Company, Inc. will post 1.51 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have issued reports on ACHC shares. Jefferies Financial Group raised Acadia Healthcare from a “hold” rating to a “buy” rating and boosted their target price for the company from $24.50 to $30.00 in a research report on Wednesday, June 3rd. TD Cowen lifted their price objective on Acadia Healthcare from $30.00 to $36.00 and gave the company a “buy” rating in a research note on Tuesday, July 14th. KeyCorp boosted their price objective on Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a report on Tuesday, July 14th. Cantor Fitzgerald reissued a “neutral” rating on shares of Acadia Healthcare in a research note on Wednesday. Finally, Raymond James Financial raised Acadia Healthcare from an “outperform” rating to a “strong-buy” rating and set a $39.00 target price for the company in a research report on Monday, May 4th. One research analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $29.85.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.